000 01439 a2200361 4500
005 20250515060929.0
264 0 _c20070330
008 200703s 0 0 eng d
022 _a2694-233X
024 7 _a10.1377/hlthaff.26.2.483
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKesselheim, Aaron S
245 0 0 _aConfidentiality laws and secrecy in medical research: improving public access to data on drug safety.
_h[electronic resource]
260 _bHealth affairs (Project Hope)
_c
300 _a483-91 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAccess to Information
650 0 4 _aBiomedical Research
_xlegislation & jurisprudence
650 0 4 _aClinical Trials as Topic
650 0 4 _aConfidentiality
_xlegislation & jurisprudence
650 0 4 _aDisclosure
650 0 4 _aDrug Approval
650 0 4 _aDrug Industry
_xlegislation & jurisprudence
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
650 0 4 _aHumans
650 0 4 _aPolicy Making
650 0 4 _aProduct Surveillance, Postmarketing
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
700 1 _aMello, Michelle M
773 0 _tHealth affairs (Project Hope)
_gvol. 26
_gno. 2
_gp. 483-91
856 4 0 _uhttps://doi.org/10.1377/hlthaff.26.2.483
_zAvailable from publisher's website
999 _c16896664
_d16896664